Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis

Journal of Neurochemistry

Volumn 73, Issue 1, 1999, Pages 179-186

  Murphy, Niall P ^a,b   Maidment, Nigel T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dopamine; GABA; Mesolimbic; Microdialysis; Nociceptin; Orphanin FQ

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BICUCULLINE; GLUTAMIC ACID; NOCICEPTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; LIMBIC CORTEX; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; VENTRAL TEGMENTUM;

AMINO ACIDS; ANIMALS; BICUCULLINE; DOPAMINE; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; MICRODIALYSIS; MICROINJECTIONS; NUCLEUS ACCUMBENS; OPIOID PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; VENTRAL TEGMENTAL AREA;

ANIMALIA;

EID: 0033000841     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0730179.x     Document Type: Article

References (53)

1. Bunzow J. R., Saez C., Mortrud M., Bouvier C., Williams J, T., Low M., and Grandy D. K. (1994) Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett. 347, 284-288.
2. Chen Y., Fan Y., Liu J., Mestek A., Tian M., Kozak C. A., and Yu L. (1994) Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347, 279-283.
3. Chergui K., Charlety P. J., Akaoka H., Saunier C. F., Brunet J. L., Buda M., Svensson T. H., and Chovet G. (1993) Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur. J. Neurosci. 5, 137-144.
4. Connor M., Vaughan C. W., Chieng B., and Christie M. J. (1996) Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br. J. Pharmacol. 119, 1614-1618.
5. Devine D. P., Leone P., Pocock D., and Wise R. A. (1993) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266, 1236-1246.
6. Devine D. P., Reinscheid R. K., Monsma F. J. Jr., Civelli O., and Akil H. (1996a) The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727, 225-229.
7. Devine D. P., Taylor L., Reinscheid R. K., Monsma F. J. Jr., Civelli O., and Akil H. (1996b) Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem. Res. 21, 1387-1396.
8. Fiorillo C. D. and Williams J. T. (1998) Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature 394, 78-82.
9. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., Houtani T., and Sugimoto T. (1994) cDN A cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 343, 42-46.
10. Grisel J. E., Mogil J. S., Belknap J. K., and Grandy D. K. (1996) Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuroreport 7, 2125-2129.
11. Henderson G. and McKnight A. T. (1997) The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18, 293-300.
12. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., and Kumanishi T. (1998) Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J. Comp. Neurol. 399, 139-151.
13. A receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats. J. Neurochem. 69, 137-143.
14. Jenck F., Moreau J. L., Martin J. R., Kilpatrick G. J., Reinscheid R. K., Monsma F. J. Jr., Nothacker H. P., and Civelli O. (1997) Orphanin FQ acts as an anxiolylic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. USA 94, 14854-14858.
15. Jiang Z. G., Pessia M., and North R. A. (1993) Dopamine and baclofen inhibit the hyperpolarization-activated cation current in rat ventral tegmental neurones. J. Physiol. (Lond.) 462, 753-764.
16. Johnson S. W. and North R. A. (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J.. Neurosci. 12, 483-488.
17. Johnson S. W., Seutin V., and North R. A. (1992) Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump. Science 258, 665-667.
18. Kalivas P. W., Duffy P., and Barrow J. (1989) Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J. Pharmacol. Exp. Ther. 251, 378-387.
19. Kalivas P. W., Churchill L., and Klitenick M. A. (1993) GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 57, 1047-1060.
20. Konya H., Masuda H., Itoh K., Nagai K., Kakishita E., and Matsuoka A. (1998) Modification of dopamine release by nociceptin in conscious rat striatum. Brain Res. 788, 341-344.
21. Lachowicz J. E., Shen Y., Monsma F. J. Jr., and Sibley D. R. (1995) Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J. Neurochem. 64, 34-40.
22. Maidment N. T., Brumbaugh D. R., Rudolph V. D., Erdelyi E., and Evans C. J. (1989) Microdialysis of extracellular endogenous opioid peptides from rat brain in vivo. Neuroscience 33, 549-557.
23. Maidment N. T., Siddall B. J., Rudolph V. R., Erdelyi E., and Evans C. J. (1991) Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: microdialysis combined with a sequential multiple antigen radioimmunoassay. Neuroscience 45, 81-93.
24. Matthes H., Seward E. P., Kieffer B., and North R. A. (1996) Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes. Mol. Pharmacol. 50, 447-450.
25. Meunier J. C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J. L., Guillemot J. C., Ferrara P., Monsarrat B., et al. (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377, 532-535.
26. Mogil J. S., Grisel J. E., Reinscheid R. K., Civelli O., Belknap J. K., and Grandy D. K. (1996a) Orphanin FQ is a functional anti-opioid peptide. Neuroscience 75, 333-337.
27. Mogil J. S., Grisel J. E., Zhangs G., Belknap J. K., and Grandy D. K. (1996b) Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci. Lett. 214, 131-134.
28. Mollereau C., Parmentier M., Mailleux P., Butour J. L., Moisand C., Chalon P., Caput D., Vassart G., and Meunier J. C. (1994) ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341, 33-38.
29. Murphy N. P., Ly H. T., and Maidment N. T. (1996) Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience 75, 1-4.
30. + evoked glutamate release from rat cerebrocortical slices. Br. J. Pharmacol. 119, 1081-1083.
31. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edit. Academic Press, Sydney.
32. Reinscheid R. K., Nothacker H. P., Bourson A., Ardati A., Henningsen R. A., Bunzow J. R., Grandy D. K., Langen H., Monsma F. J. Jr., and Civelli O. (1995) Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270, 792-794.
33. Salord F., Keita H., Lecharny J. B., Henzel D., Desmonts J. M., and Mantz J. (1997) Halothane and isoflurane differentially affect the regulation of dopamine and gamma-aminobutyric acid release mediated by presynaptic acetylcholine receptors in the rat striaturn. Anesthesiology 86, 632-641.
34. Sesack S. R. and Pickel V. M. (1995) Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitters in the rat ventral tegmental area. Brain Res. 672, 261-275.
35. Seutin V., Johnson S. W., and North R. A. (1994) Effect of dopamine and baclofen on N-methyl-D-aspartate-induced burst firing in rat ventral tegmental neurons. Neuroscience 58, 201-206.
36. Sinchak K., Hendricks D. G., Baroudi R., and Micevych P. E. (1997) Orphanin FQ/nociceptin in the ventromedial nucleus facilitates lordosis in female rats. Neuroreport 8, 3857-3860.
37. Spanagel R., Herz A., and Shippenberg T. S. (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55, 1734-1740.
38. Spanagel R., Herz A., and Shippenberg T. S. (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA 89, 2046-2050.
39. Stinus L., Koob G. F., Ling N., Bloom F. E., and Le Moal M. (1980) Locomotor activation induced by infusion of endorphins into the ventral tegmental area: evidence for opiate-dopamine interactions. Proc. Natl. Acad. Sci. USA 77, 2323-2327.
40. Stratford T. R., Holahan M. R., and Kelley A. E. (1997) Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. Neuroreport 8, 423-426.
41. Suaud-Chagny M. F., Chergui K., Chouvet G., and Gonon F. (1992) Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience 49, 63-72.
42. Timmerman W. and Westerink B. H. (1997) Brain microdialysis of GABA and glutamate: what does it signify? Synapse 27, 242-261.
43. Vaughan C. W., Ingram S. L., and Christie M. J. (1997) Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci. 17, 996-1003.
44. + conductance. Neuroendocrinology 67, 73-82.
45. Wang J. B., Johnson P. S., Imai Y., Persico A. M., Ozenberger B. A., Eppler C. M., and Uhl G. R. (1994) cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett. 348, 75-79.
46. Wang T., O'Connor W. T., Ungerstedt U., and French E. D. (1994) N-Methyl-D-aspartic acid biphasically regulates the biochemical and electrophysiological response of A10 dopamine neurons in the ventral tegmental area: in vivo microdialysis and in vitro electrophysiological studies. Brain Res. 666, 255-262.
47. Watanabe K., Arai T., Aoki M., Mori H., and Mori K. (1993) Effects of halothane on the synthesis of neurotransmitter amino acids in mouse brain. Acta Anaesthesiol. Scand. 37, 706-709.
48. Westerink B. H., Kwint H. F., and de Vries J. B. (1996) The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J. Neurosci. 16, 2605-2611.
49. Wick M. J., Minnerath S. R., Lin X., Elde R., Law P. Y., and Loh H. H. (1994) Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. Brain Res. Mol. Brain Res. 27, 37-44.
50. Wise R. A. (1988) Psychomotor stimulant properties of addictive drugs. Ann. NY Acad. Sci. 537, 228-234.
51. Xu X. J., Hao J. X., and Wiesenfeld-Hallin Z. (1996) Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport 7, 2092-2094.
52. Yoshida M., Yokoo H., Tanaka T., Emoto H., and Tanaka M. (1994) Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. Brain Res. 636, 111-114.
53. Yu T. P., Fein J., Phan T., Evans C. J., and Xie C. W. (1997) Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus 7, 88-94.